Role of percutaneous arterial embolization in renal pathology

被引：4

作者：

Loffroy, R. ^{[1
]}

Abualsaud, B. ^{[1
]}

Delgal, A. ^{[2
]}

Guiu, B. ^{[1
]}

Kermarrec, I. ^{[2
]}

Michel, F. ^{[2
]}

Cormier, L. ^{[2
]}

Mousson, C. ^{[3
]}

Majbri, N. ^{[3
]}

Rebibou, J. -M. ^{[3
]}

Cercueil, J. -P. ^{[1
]}

Krause, D. ^{[1
]}

机构：

[1] CHU Bocage, Dept Radiol Diagnost & Therapeut, F-21079 Dijon, France

[2] CHU Bocage, Serv Chirurg Urol & Androl, F-21079 Dijon, France

[3] CHU Bocage, Serv Nephrol & Transplantat Renale, F-21079 Dijon, France

来源：

PROGRES EN UROLOGIE | 2010年 / 20卷 / 03期

关键词：

Kidney; Arterial embolizaion; Interventional radiology; LONG-TERM OUTCOMES; TUBEROUS SCLEROSIS; CELL CARCINOMA; NEPHRECTOMY; ANGIOMYOLIPOMAS; COMPLICATIONS; HYPERTENSION; IMMEDIATE; INJURIES; SURVIVAL;

D O I：

10.1016/j.purol.2009.07.001

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Therapeutic embolization in renal pathology is used for various conditions in cancerology, traumatology, urology, nephrology and for iatrogenic complications of percutaneous manoeuvers. Any department of vascular radiology may be requested to use this technique, especially in emergent traumatology or palliative cancerology. The authors study the various conditions that may benefit from these procedures and give the highlights of the main indications and the main types of embolic agents used. Complications, side effects and the major precautions are also reviewed. (C) 2009 Elsevier Masson SAS. All rights reserved.

引用

页码：161 / 171

页数：11